Medulloblastoma, Group 4
2 clinical trials · Condition
◉ Watch Medulloblastoma, Group 4
| Record | Firm | Date |
|---|---|---|
| SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors (NCT03434262) | St. Jude Children's Research Hospital | 2018-03-05 |
Track Medulloblastoma, Group 4 automatically
Every clearance here is in the API, with alerts when new ones post.